Fluid therapy and outcome: balance is best.
The use of intravenous fluids is routine in patients undergoing surgery or critical illness; however, controversy still exists regarding optimum fluid therapy. Recent literature has examined the effects of different types, doses, and timing of intravenous fluid therapy. Each of these factors may influence patient outcomes. Crystalloids consist of isotonic saline or balanced electrolyte solutions and widely distribute across extracellular fluid compartments, whereas colloids contain high-molecular-weight molecules suspended in crystalloid carrier solution and do not freely distribute across the extracellular fluid compartments. Colloids vary in composition and associated potential adverse effects. Recent evidence has highlighted safety and ethical concerns regarding the use of colloid solutions in critically ill patients, particularly the use of synthetic starch solutions, which have been associated with increased morbidity and mortality. Crystalloid solutions with a chloride-rich composition (e.g., isotonic saline) have been associated with metabolic acidosis, hyperchloremia, increased incidence of acute kidney injury, and increased requirement for renal replacement therapy. An optimum dose of intravenous fluids remains controversial with no definitive evidence to support restrictive versus liberal approaches. Further high-quality trials are needed to elucidate the optimum fluid therapy for patients, but currently a balanced approach to type, dose, and timing of fluids is recommended.
Sara J
SJ
Allen
D006348:Cardiac Surgical Procedures / Q000401:mortality*; D019317:Evidence-Based Medicine; D005440:Fluid Therapy / Q000379:methods* / Q000401:mortality*; D006801:Humans; D015994:Incidence; D019990:Perioperative Care / Q000401:mortality*; D011183:Postoperative Complications / Q000401:mortality* / Q000517:prevention & control*; D018570:Risk Assessment; D016896:Treatment Outcome